Monte Rosa Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.89
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.65
|
0.00
|
0.65
|
100.00%
|
|
2022-12-31
|
-0.63
|
0.00
|
0.63
|
100.00%
|
|
2022-09-30
|
-0.60
|
-0.58
|
0.02
|
3.33%
|
|
2022-06-30
|
-0.54
|
-0.57
|
-0.03
|
-5.56%
|
|
2022-03-31
|
-0.52
|
-0.51
|
0.01
|
1.92%
|
|
2021-12-31
|
-0.50
|
-0.93
|
-0.43
|
-86.00%
|
|
2021-09-30
|
-0.44
|
-0.43
|
0.01
|
2.27%
|
|
2021-06-30
|
-0.40
|
-3.63
|
-3.23
|
-807.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.66
|
|
2021-12-31
|
-8.05
|
|
2020-12-31
|
-7.18
|
|
2019-12-31
|
-3.04
|